Abstract
Medical and legal controversies surrounding payment for investigative treatments abound. The debate should be moved from the legal to the medical arena, and health plans should support the quest for scientific evidence by contributing to well-conceived clinical trials in appropriate circumstances.
First Page
45
Recommended Citation
Mary
Ader
Investigational Treatments: Coverage, Controversy, and Consensus,
5
Annals Health L.
45
(1996).
Available at: https://lawecommons.luc.edu/annals/vol5/iss1/5